Beth Hesda Medical Corporation was founded in November 2015, is a wholly-owned R&D subsidiary of Sunny Medical in Chicago. The R&D team of the company is composed of interdisciplinary talents in the fields of medical equipment, electrical engineering and biological materials. They come from internationally renowned medical equipment enterprises and have rich experience in R&D and production. Currently, the automated peritoneal dialysis (APD) series with an international leading level, and supported by national biomedical materials, as well as the repair and replacement of tissues and organs R&D program in 2016. It is expected to be licensed by the U.S. FDA in 2019, manufactured in the U.S. proper and popularized around the world.
Peritoneal dialysis is a mature treatment technology, divided into manual (CAPD) and automatic (APD). Wearable peritoneal dialysis will be the future direction of development. APD advantages: low cost, good convenience, high degree of freedom, without interfering with the daily work.